Cargando…
Role of the Wnt-β-catenin signaling pathway in melanoma-mediated dendritic cell tolerization
Autores principales: | Holtzhausen, Alisha, Evans, Kathy, Hanks, Brent A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990981/ http://dx.doi.org/10.1186/2051-1426-1-S1-P153 |
Ejemplares similares
-
Melanoma-derived Wnt5a conditions dendritic cells to promote regulatory T cell differentiation via the upregulation of indoleamine 2,3-dioxygenase: novel pharmacological strategies for augmenting immunotherapy efficacy
por: Zhao, Fei, et al.
Publicado: (2014) -
Early Carcinogenesis Involves the Establishment of Immune Privilege via Intrinsic and Extrinsic Regulation of Indoleamine 2,3-dioxygenase-1: Translational Implications in Cancer Immunotherapy
por: Holtzhausen, Alisha, et al.
Publicado: (2014) -
Pharmacological Wnt ligand inhibition overcomes key tumor-mediated resistance pathways to anti-PD-1 immunotherapy
por: DeVito, Nicholas C., et al.
Publicado: (2021) -
Nomogram Incorporating the WNT/β-Catenin Signaling Pathway for Predicting the Survival of Cutaneous Melanoma
por: Zhou, Yu-Xin, et al.
Publicado: (2021) -
Role of Tumor-Mediated Dendritic Cell Tolerization in Immune Evasion
por: DeVito, Nicholas C., et al.
Publicado: (2019)